Björklund Pharma AS is a biopharmaceutical company specializing in biofactors, i.e., essential substances crucial for the body’s normal physiological functions, health enhancement, and disease prevention. The company focuses on critical medical needs through innovative research and development of biopharmaceutical solutions to combat diseases.

Björklund Pharma’s expertise encompasses various compounds, including vitamins, pro-vitamins, minerals, trace elements, enzymes, peptides, amino acids, fatty acids, and phytochemicals. Given its early-stage status, the company is poised to make significant strides in advancing biopharmaceutical innovation and improving healthcare outcomes. Geir Bjørklund, MD, the CEO and Chairman, guides the company’s mission and strategic direction.